200,000+ products from a single source!
sales@angenechem.com
Home > Other Building Blocks > 15883-20-2
15883-20-2 | 2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
CAS No: 15883-20-2 Catalog No: AG001QWL MDL No:MFCD01701244
Product Description
Catalog Number:
AG001QWL
Chemical Name:
2-Piperidinecarboxamide, N-(2,6-dimethylphenyl)-
CAS Number:
15883-20-2
Molecular Formula:
C14H20N2O
Molecular Weight:
232.3214
MDL Number:
MFCD01701244
IUPAC Name:
N-(2,6-dimethylphenyl)piperidine-2-carboxamide
InChI:
InChI=1S/C14H20N2O/c1-10-6-5-7-11(2)13(10)16-14(17)12-8-3-4-9-15-12/h5-7,12,15H,3-4,8-9H2,1-2H3,(H,16,17)
InChI Key:
SILRCGDPZGQJOQ-UHFFFAOYSA-N
SMILES:
O=C(C1CCCCN1)Nc1c(C)cccc1C
Properties
Complexity:
257
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
232.158g/mol
Formal Charge:
0
Heavy Atom Count:
17
Hydrogen Bond Acceptor Count:
2
Hydrogen Bond Donor Count:
2
Isotope Atom Count:
0
Molecular Weight:
232.327g/mol
Monoisotopic Mass:
232.158g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
41.1A^2
Undefined Atom Stereocenter Count:
1
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3
Literature
| Title | Journal |
|---|---|
| Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children. | British journal of anaesthesia 20110901 |
| Pharmacokinetics of ropivacaine in patients with chronic renal failure. | British journal of anaesthesia 20110401 |
| Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro. | Basic & clinical pharmacology & toxicology 20060201 |
| Nonaromatic hydroxylation of bupivacaine during continuous epidural infusion in man. | Journal of biochemical and biophysical methods 20030829 |
| Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection. | Electrophoresis 20030701 |
| Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine. | The Journal of pharmacy and pharmacology 20030701 |
| Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. | Anesthesia and analgesia 20030201 |
| Effect of ciprofloxacin on the pharmacokinetics of ropivacaine. | European journal of clinical pharmacology 20030201 |
| Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores. | European journal of medicinal chemistry 20010301 |
| Acute cardiovascular and central nervous system toxicity of bupivacaine and desbutylbupivacaine in the rat. | Acta anaesthesiologica Scandinavica 19920201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.